TMDX
Transmedics Group Inc
Price:  
67.53 
USD
Volume:  
1,328,386.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TMDX WACC - Weighted Average Cost of Capital

The WACC of Transmedics Group Inc (TMDX) is 8.5%.

The Cost of Equity of Transmedics Group Inc (TMDX) is 9.05%.
The Cost of Debt of Transmedics Group Inc (TMDX) is 5.80%.

Range Selected
Cost of equity 7.50% - 10.60% 9.05%
Tax rate 0.60% - 3.00% 1.80%
Cost of debt 4.80% - 6.80% 5.80%
WACC 7.0% - 9.9% 8.5%
WACC

TMDX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.8 1.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.50% 10.60%
Tax rate 0.60% 3.00%
Debt/Equity ratio 0.22 0.22
Cost of debt 4.80% 6.80%
After-tax WACC 7.0% 9.9%
Selected WACC 8.5%

TMDX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for TMDX:

cost_of_equity (9.05%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.8) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.